Profile
Jean-Cosme Dodart worked as a Director at The Brigham & Women's Hospital, Inc. and as a Pharmacology Director at SAGE Therapeutics, Inc. He also held positions as a Principal at Eli Lilly & Co. and Merck & Co., Inc. Additionally, he was a Neurology Professor at Harvard Medical School.
Dodart received a graduate degree from Université Pierre et Marie Curie and a doctorate from the University of Strasbourg.
Former positions of Jean-Cosme Dodart
| Companies | Position | End |
|---|---|---|
| SAGE THERAPEUTICS, INC. | Corporate Officer/Principal | - |
| MERCK & CO., INC. | Corporate Officer/Principal | - |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - |
| Harvard Medical School | Corporate Officer/Principal | - |
The Brigham & Women's Hospital, Inc.
 The Brigham & Women's Hospital, Inc. Hospital/Nursing ManagementHealth Services The Brigham & Women's Hospital, Inc. provides health care services. The firm offers treatment for cancer, cardio vascular, neurosciences, orthopedic, arthritis, women's health and clinical services. The company was founded in 1980 and is headquartered in Boston, MA. | Corporate Officer/Principal | - |
Training of Jean-Cosme Dodart
| University of Strasbourg | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| SAGE THERAPEUTICS, INC. | Health Technology |
| ELI LILLY AND COMPANY | Health Technology |
| MERCK & CO., INC. | Health Technology |
| Private companies | 2 |
|---|---|
The Brigham & Women's Hospital, Inc.
The Brigham & Women's Hospital, Inc. Hospital/Nursing ManagementHealth Services The Brigham & Women's Hospital, Inc. provides health care services. The firm offers treatment for cancer, cardio vascular, neurosciences, orthopedic, arthritis, women's health and clinical services. The company was founded in 1980 and is headquartered in Boston, MA. | Health Services |
| Université Pierre et Marie Curie | Consumer Services |
- Stock Market
- Insiders
- Jean-Cosme Dodart
